Scholars Central

Search Scholars Central

Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.

Advanced searchHide advanced search

In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:

Years

1–24 of 24 articles for Semaglutide

Then save them, add them to a collection or cite them together.
  1. Article · 9 Dec 2024

    Comparative Bioavailability Study of Rybelsus (Semaglutide) 3 mg Tablets of Novo Nordisk Versus Ozempic (Semaglutide) 2 mg/1.5 ml (1.34 mg/ml) Solution for Injection of Novo Nordisk under Fasting Condition in Healthy Subjects

    Journal of Bioequivalence & Bioavailability · Volume 16, Issue 6

    Background: The human GLP-1 receptor agonist, semaglutide, functions by binding to albumin, which is facilitated by modifying position 26 lysine with a hydrophilic spacer and a C18 fatty ... acid. In this study, Novo…

  2. Perspective · 15 Feb 2022

    Semaglutide Single Dose Pen-Injector

    Journal of Obesity and Metabolism · Volume 5, Issue 1

    Subcutaneous semaglutide, delivered by a single-dose pen-injector at a maintenance dose of 2.4mg once weekly, is approved in the USA for weight management in people with ... higher and a minimum of one obesity-related…

  3. Conference abstract · 28 Sep 2022

    New Glp1a and Diabetes controlle

    glucagon-like peptide-1 receptor agonist (GLP-1RA) semaglutide is the most recently approved agent of this drug class, and the only GLP-1RA currently available as both subcutaneous ... control and cause weight loss…

  4. Conference abstract · 25 May 2023

    Obesity Medications: The new wonder drugs

    hyperlipidemia. Evidence has demonstrated that Diabetes medications such as GLP-1 agonists, such as semaglutide, are gaining a lot of recognition for their weight loss effects, equivalent to weight loss ... rates seen…

  5. Conference abstract · 9 Oct 2023

    Does medications work in childhood obesity

    approved Anti-obesity medications include Orlistat, Phentermine/Topirmate, Bupropion/Naltrexone, Liraglutide 3 mg and Semaglutide 2.4 mg. These medications don’t work by themselves. They reinforce the patient’s intention

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels